We are live on ! Find out more
TG

TRV GP Portfolio holdings

AUM $18.9M
1-Year Est. Return 541.67%
This Fund
S&P 500
This Quarter Est. Return
+96.3%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
10 Year Est. Return
AUM
$101M
AUM Growth
+$762K
Cap. Flow
-$28.7M
Cap. Flow %
-28.46%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$28.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$7.28B
$54.3M 53.78%
1,981,437
-1,000,000
-34% -$28.7M
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$41.1M 40.71%
3,034,083
CARM
3
DELISTED
Carisma Therapeutics
CARM
$4.99M 4.94%
242,080
LRMR icon
4
Larimar Therapeutics
LRMR
$381M
$576K 0.57%
17,531

Similar funds

TRV GP's Q1 2019 Portfolio in Review

As of Q1 2019, TRV GP held 4 positions worth $101M, up 0.76% from $100M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP withdrew a net $28.7M in Q1 2019, reducing 1 holding. Its largest reduction was Rhythm Pharmaceuticals, cutting an estimated $28.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP's biggest Q1 2019 reduction was Rhythm Pharmaceuticals, cutting an estimated $28.7M.
  • TRV GP's ten largest holdings make up 100% of its $101M portfolio in Q1 2019.
  • TRV GP opened 0 new positions and closed 0 in Q1 2019.
  • TRV GP's portfolio value rose 0.76% quarter-over-quarter to $101M.

Based on TRV GP's 13F filing for Q1 2019, filed 3 May 2019.